Rybelsus® 7mg Semaglutide Tablets

Rybelsus® 7mg is an oral tablet containing semaglutide, a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is a prescription medicine intended for use under the supervision of a licensed healthcare professional.

Rybelsus® provides an oral semaglutide option for patients who are prescribed GLP-1 receptor agonist therapy. The 7mg strength is commonly used as a maintenance or dose-escalation strength after an initial starting period, according to a healthcare provider’s treatment plan.

产品信息：

• 产品名称： Rybelsus® 7mg Semaglutide Tablets
• Japanese Name: リベルサス錠7mg
• Chinese Name: Rybelsus® 7mg（Semaglutide）口服錠
• Active Ingredient: Semaglutide
• Strength: 7mg
• Dosage Form: Oral tablet
• Route of Administration: Oral
• Drug Class: GLP-1 receptor agonist
• Brand Owner: Novo Nordisk
• Product Type: Prescription medicine
• Use: Use only as directed by a licensed healthcare professional

What Is Rybelsus® 7mg?

Rybelsus® 7mg contains semaglutide in a once-daily oral tablet form. Semaglutide belongs to the GLP-1 receptor agonist class, which is associated with blood glucose regulation, insulin response, glucagon secretion, gastric emptying, and appetite-related signaling.

The 7mg strength is generally used after the body has adjusted to the lower starting dose. Any change from 3mg to 7mg, or from 7mg to a higher strength, should only be made according to a doctor’s instructions.

This product should not be used without medical advice, diagnosis, and prescription.

主要特点

Rybelsus® 7mg is known for:

• Contains semaglutide 7mg
• Oral tablet format
• Once-daily administration as directed
• Belongs to GLP-1 receptor agonist class
• Non-injectable semaglutide option
• Commonly used after the initial starting dose
• Manufactured by Novo Nordisk
• Prescription-only medicine
• Should be used with medical monitoring and lifestyle guidance

About Semaglutide

Semaglutide is a GLP-1 receptor agonist. GLP-1 receptor agonists work by activating GLP-1 receptors involved in metabolic regulation.

Under healthcare professional guidance, semaglutide may help support:

• Blood glucose management
• Insulin secretion response when blood glucose is elevated
• Reduced glucagon release when appropriate
• Slower gastric emptying
• Appetite and satiety-related signaling
• Overall metabolic care as part of a treatment plan

The effect and suitability of semaglutide depend on each patient’s health condition, current medications, medical history, and doctor’s assessment.

Dose Strength Information

The 7mg strength is commonly used as a follow-up dose after the initial 3mg starting period.

A healthcare professional may determine whether 7mg is appropriate based on:

• Treatment response
• Side effects
• Blood glucose results
• Digestive tolerance
• Other medications
• Overall health condition

Patients should not increase, decrease, or stop the dose without medical advice.

How to Take Rybelsus® 7mg

Use exactly as directed by your doctor or pharmacist.

General administration guidance may include:

• Take once daily by mouth.
• Take on an empty stomach after waking.
• Take with a small amount of plain water.
• Wait before eating, drinking, or taking other oral medicines.
• Do not split, crush, or chew the tablet.
• Follow your prescribed dosing schedule carefully.

Always follow the official prescription label and your healthcare provider’s instructions.

Who May Be Prescribed Rybelsus® 7mg?

Rybelsus® 7mg may be prescribed by a healthcare professional for suitable adult patients who need GLP-1 receptor agonist therapy as part of a medical treatment plan.

A doctor may assess:

• Medical history
• Blood sugar control
• Current treatment plan
• Tolerability to semaglutide
• Digestive system condition
• Kidney and liver function
• Pregnancy or breastfeeding status
• Risk of drug interactions
• Risk of hypoglycemia when used with insulin or sulfonylureas

This medicine is not suitable for everyone.

Important Safety Information

Before using Rybelsus® 7mg, tell your healthcare provider if you:

• Have a history of pancreatitis
• Have severe stomach or intestinal problems
• Have kidney disease
• Have liver disease
• Have diabetic retinopathy
• Are pregnant, planning pregnancy, or breastfeeding
• Are taking insulin or sulfonylurea medicines
• Have a history of thyroid tumors or endocrine disorders
• Have allergies to semaglutide or any ingredient in the tablet
• Are taking other prescription or non-prescription medicines

可能的副作用

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Loss of appetite
• Indigestion
• Bloating
• Fatigue

Serious side effects may occur rarely and require medical attention.

Seek medical help immediately if you experience:

• Severe or persistent abdominal pain
• Severe vomiting or dehydration
• Signs of pancreatitis
• Allergic reaction
• Vision changes
• Symptoms of low blood sugar, especially when used with insulin or sulfonylurea
• Neck lump, difficulty swallowing, or persistent hoarseness

贮存

Store according to the product package and pharmacist instructions.

General storage recommendations:

• Keep in original packaging.
• Protect from moisture.
• Store at room temperature unless otherwise stated.
• Keep away from children and pets.
• Do not use after the expiry date.

重要说明

• Rybelsus® 7mg is a prescription medicine.
• Use only under doctor supervision.
• Do not share this medicine with others.
• Do not use for cosmetic weight loss without medical indication.
• Do not change dose without medical advice.
• It is not a substitute for diet, exercise, or diabetes care.
• Individual results and tolerability vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Related products and categories: View Rybelsus 3mg Semaglutide Tablets, Rybelsus 14mg Semaglutide Tablets, or browse our GLP-1 Medication category for more prescription medicine information.

Rybelsus 3mg Semaglutide Tablets: https://pdbeauty.store/product/rybelsus-3mg-semaglutide-tablets/
Rybelsus 14mg Semaglutide Tablets: https://pdbeauty.store/product/rybelsus-14mg-semaglutide-tablets/
GLP-1 Medication: https://pdbeauty.store/product-category/maintenance-skin-care/weight-management/glp-1-medication/